25 May 2013
Keywords: trexima, receives, second, approvable, letter, uk, drug
Article | 13 August 2007
UK drug major GlaxoSmithKline and US pharmaceutical firm Pozen have received a second US Food and Drug Administration "approvable letter"
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
13 August 2007
24 May 2013
© 2013 thepharmaletter.com